MoodRhythm Wins mHealth Award For Bipolar App
Innovative mHealth application MoodRhythm helps people suffering from bipolar disorder learn about and monitor their personal rhythms and has recently won the $100,000 Heritage Open mHealth Challenge.
The challenge to develop mHealth application that would deliver open communication and function across multiple devices was co-sponsored by Heritage Provider Network, Open mHealth, and the University of California, Los Angeles.
MoodRhythm was developed by a team led by Tanzeem Choudhury and uses a phone’s microphone, light sensors and accelerometer to monitor sleep and social patterns and combines this information with what the patient reports about daily activities, food routines and mood to learn what situations have positive or negative outcomes. The app gives the patient helpful advice to maintain a regular daily rhythm, while gathering vital information for the patient’s doctor. The team is contributing a routine, sleep, and sensing module to Open mHealth.
“Rhythms guide our lives,” Choudhury says. “Our biological clocks tell us when we need to sleep, eat and wake. When these rhythms are interrupted or obstructed, it can be difficult for our bodies to get what they need to stay healthy and balanced.”
Bipolar disorder, also called manic depression, affects some 5.7 million American adults in a given year and is characterized by extreme mood swings from a happy, hyperactive state to extreme depression. It is associated with poor functional and clinical outcomes, high suicide rates and huge societal costs.
The app can replace traditional paper diaries that patients often find difficult to maintain. It was designed in collaboration with patients and clinicians, and is based on Choudhury’s earlier experiments with using smartphones sensors to detect social interactions, stress and sleep. To protect privacy, the phone does not listen in on the content of speech, but notes variations in pitch, volume, speaking rate and other characteristics to measure emotional states.
“It is one of the greatest challenges in health care to develop cutting-edge technology that not only meets clinical needs but that can be incorporated with ease into patients’ lives,” Choudhury said.
Learn More About MoodRhythm
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”